Bristol Myers discloses patient death in early-stage cell therapy study

Oct 23 (Reuters) – Bristol Myers Squibb on Friday disclosed a patient death in an early-stage trial studying its experimental CAR T cell therapy.

Shares of the drugmaker were trading 2.5% lower in early trading.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)

Brought to you by www.srnnews.com

Click here to read the full article